Original Research
Published on 05 Feb 2021
C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation
in Vaccines and Molecular Therapeutics

- 3,381 views
- 7 citations
Original Research
Published on 05 Feb 2021
in Vaccines and Molecular Therapeutics

Review
Published on 05 Feb 2021
in Inflammation

Original Research
Published on 05 Feb 2021
in Molecular Innate Immunity

Original Research
Published on 05 Feb 2021
in Autoimmune and Autoinflammatory Disorders

Review
Published on 05 Feb 2021
in B Cell Biology

Original Research
Published on 05 Feb 2021
in Vaccines and Molecular Therapeutics

Mini Review
Published on 05 Feb 2021
in Nutritional Immunology

Review
Published on 05 Feb 2021
in Primary Immunodeficiencies

Review
Published on 05 Feb 2021
in Vaccines and Molecular Therapeutics

Original Research
Published on 05 Feb 2021
in B Cell Biology

Original Research
Published on 05 Feb 2021
in Mucosal Immunity

Original Research
Published on 04 Feb 2021
in Autoimmune and Autoinflammatory Disorders

Original Research
Published on 04 Feb 2021
in Autoimmune and Autoinflammatory Disorders

Original Research
Published on 04 Feb 2021
in Cancer Immunity and Immunotherapy

Review
Published on 04 Feb 2021
in T Cell Biology

Review
Published on 04 Feb 2021
in Multiple Sclerosis and Neuroimmunology
